(Q37363572)

19 August 2017

1 reference

title

The management of haemoglobinopathies (English)

1 reference

19 August 2017

Davies SC

1

1 reference

19 August 2017

Wonke B

series ordinal

2

1 reference

19 August 2017

publication date

1 April 1991

1 reference

Best Practice and Research: Clinical Haematology

19 August 2017

published in

1 reference

19 August 2017

volume

4

1 reference

19 August 2017

issue

2

1 reference

19 August 2017

page(s)

361-389

1 reference

High incidence of cardiomyopathy in beta-thalassaemia patients receiving regular transfusion and iron chelation: reversal by intensified chelation

19 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980164-7

7 January 2021

Long-term trial with the oral iron chelator 1,2-dimethyl-3-hydroxypyrid-4-one (L1). II. Clinical observations

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980164-7

7 January 2021

Gall stones in sickle cell disease in the United Kingdom

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980164-7

7 January 2021

Effect of age at the start of iron chelation therapy on gonadal function in beta-thalassemia major

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980164-7

7 January 2021

Acute admissions of patients with sickle cell disease who live in Britain

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980164-7

7 January 2021

Control of homozygous beta-thalassemia by carrier screening and antenatal diagnosis in Sardinians

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980164-7

7 January 2021

Exposure of patients to human immunodeficiency virus through the transfusion of blood components that test antibody-negative

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980164-7

7 January 2021

Penicillin prophylaxis in children with sickle cell disease in Brent

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980164-7

7 January 2021

The presentation, management and prophylaxis of sickle cell disease

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980164-7

7 January 2021

Acute chest syndrome in sickle-cell disease

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980164-7

7 January 2021

Upper airways obstruction and cerebrovascular accident in children with sickle cell anaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980164-7

7 January 2021

Prophylaxis with oral penicillin in children with sickle cell anemia. A randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980164-7

7 January 2021

Patterns of mortality in sickle cell disease in the United Kingdom

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980164-7

7 January 2021

Iron toxicity and oxygen radicals

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980164-7

7 January 2021

Hepatic sequestration in sickle cell anaemia.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980164-7

7 January 2021

Measurement of regional cerebral blood flow, blood volume and oxygen metabolism in patients with sickle cell disease using positron emission tomography

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980164-7

7 January 2021

Growth retardation in sickle-cell disease treated by nutritional support

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980164-7

7 January 2021

The Interaction of Alpha-Thalassemia and Homozygous Sickle-Cell Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980164-7

7 January 2021

Incidence of overt and covert neurological damage in children with sickle cell disease

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980164-7

7 January 2021

Bone marrow transplantation in patients with thalassemia

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980164-7

7 January 2021

Desferrioxamine to improve cardiac function in iron-overloaded patients with thalassemia major

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980164-7

7 January 2021

Effect of fetal diagnostic testing on birth-rate of thalassaemia major in Britain

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980164-7

7 January 2021

Intradermal hepatitis B vaccine in thalassaemia and sickle cell disease

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980164-7

7 January 2021

Hepatitis B or non-A, non-B virus infection in multitransfused thalassaemic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980164-7

7 January 2021

Visual and auditory neurotoxicity in patients receiving subcutaneous deferoxamine infusions

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980164-7

7 January 2021

B19 virus--a pathogenic human parvovirus

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980164-7

7 January 2021

Growth patterns by age and sex in children with sickle cell disease

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980164-7

7 January 2021

Impaired growth hormone (GH) response to GH-releasing hormone in thalassemia major

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980164-7

7 January 2021

Influence of sickle hemoglobinopathies on growth and development

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980164-7

7 January 2021

Social integration of the older thalassaemic patient

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980164-7

7 January 2021

The toxic effects of desferrioxamine

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980164-7

7 January 2021

The development of iron chelating drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980164-7

7 January 2021

The natural history of stroke in sickle cell disease

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980164-7

7 January 2021

Early rise in the "pitted" red cell count as a guide to susceptibility to infection in childhood sickle cell anaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980164-7

7 January 2021

Primary hypothyroidism and the low T3 syndrome in thalassaemia major

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980164-7

7 January 2021

Depressed serum somatomedin activity in beta-thalassemia

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980164-7

7 January 2021

Stilboestrol and stuttering priapism in homozygous sickle-cell disease

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980164-7

7 January 2021

Early HIV infection: to treat or not to treat?

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980164-7

7 January 2021

Association of thalassaemia intermedia with a beta-globin gene haplotype

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980164-7

7 January 2021

Acute splenic sequestration and hypersplenism in the first five years in homozygous sickle cell disease

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980164-7

7 January 2021

Bone marrow transplantation in five children with sickle cell anaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980164-7

7 January 2021

Alloimmunization in sickle cell anemia and transfusion of racially unmatched blood

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980164-7

7 January 2021

Gall stones in Jamaican children with homozygous sickle cell disease

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980164-7

7 January 2021

Reversal of desferrioxamine induced auditory neurotoxicity during treatment with Ca-DTPA

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980164-7

7 January 2021

Antibody to hepatitis C virus in multiply transfused patients with thalassaemia major

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980164-7

7 January 2021

10.1016/S0950-3536(05)80164-7

Identifiers

DOI

1 reference

19 August 2017

1 reference